News & Media

Basser cancer and surgery specialists Drs. Kara Maxwell, Daniel Lee, Jennifer Zhang, and Bryson Katona delve into the nuances of BRCA-positive breast, prostate, and pancreatic cancers in men.

Basser executive director Susan M. Domchek, MD and Abramson Cancer Center director Robert H. Vonderheide, MD, DPhil have been elected as Fellows of the 2025 American Association for Cancer Research (AACR) Academy.

Katherine Nathanson, MD discusses the impact of reversion mutations on resistance to PARP inhibitors across various DNA damage repair genes.

Katherine Nathanson, MD, director of Genetics at the Basser Center, discussed next steps for identifying how breast cancers become resistant to treatment.

Susan Domchek, MD, director of the Basser Center, will receive the American Society of Clinical Oncology’s 2025 ASCO-American Cancer Society Cancer Prevention Award at the ASCO Annual Meeting.

Genetic testing for BRCA1 and BRCA2 can reveal if you have an increased risk of developing cancer, but it’s not universally recommended for everyone. Payal Shah, MD says testing should be considered for those with family history of certain cancers.

Susan Domchek, MD has been recognized by the American Society of Clinical Oncology with one of the society’s highest honors, as the 2025 recipient of the ASCO-American Cancer Society Cancer Prevention Award.

Katherine Nathanson, MD, the Pearl Basser Professor for BRCA-Related Research, discussed new BRCA research she presented at the San Antonio Breast Cancer Symposium 2024.

Patrick Sung, DPhil, of UT Health Science Center of San Antonio, is awarded the 2024 Basser Global Prize for his cutting-edge work in the field of DNA damage repair.

Kara Maxwell, MD, PhD, and genetic counselor Jacquelyn Powers, MS, LCGC, from the Basser Center for BRCA created a resource to help counsel individuals with cancer-related genetic mutations about reproductive risks.